Faculty Profiles - NAKAYAMA Goro

Papers - NAKAYAMA Goro

Division display >> ／ All the affair displays 1 - 152 of about 152

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)

Taniguchi, H; Uehara, K; Ishikawa, T; Okochi, O; Akazawa, N; Okuda, H; Hasegawa, H; Shiozawa, M; Kataoka, M; Satake, H; Shimura, T; Kondoh, C; Kuramochi, H; Matsumoto, T; Takegawa, N; Yamaguchi, T; Nagase, M; Nakamura, M; Takano, N; Fujita, H; Watanabe, T; Nishina, T; Sakamoto, Y; Moriwaki, T; Ohori, H; Nakanishi, M; Kito, Y; Utsunomiya, S; Ishikawa, T; Manaka, D; Matsuoka, H; Suto, T; Arai, T; Shinzaki, S; Funakoshi, T; Nakayama, G; Negoro, Y; Tsuji, Y; Makiyama, A; Takuma, K; Arimoto, A; Shinozaki, K; Mishima, A; Masuishi, T

CANCERS Vol. 17 ( 3 ) 2025.2

Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).

Hattori, M; Hattori, N; Nakayama, G; Umeda, S; Kishida, T; Kawase, Y; Ezaka, K; Tsutsuyama, M; Sakai, M; Ito, T; Yanbe, Y; Kanda, M; Tanaka, C; Murotani, K; Ando, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 43 ( 4_SUPPL ) page： 124 - 124 2025.2

Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases

Fujimoto, K; Koyama, F; Kobayashi, H; Kotake, K; Kawasaki, M; Kanemitsu, Y; Kinugasa, Y; Ueno, H; Maeda, K; Suto, T; Itabashi, M; Funahashi, K; Ozawa, H; Noura, S; Ishida, H; Ohue, M; Kiyomatsu, T; Ishihara, S; Koda, K; Baba, H; Kawada, K; Hashiguchi, Y; Goi, T; Toiyama, Y; Tomita, N; Sunami, E; Fujita, F; Watanabe, J; Hakamada, K; Nakayama, G; Sugihara, K; Ajioka, Y

ANNALS OF GASTROENTEROLOGICAL SURGERY 2025.1

FAM32A Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer

Agatsuma, Y; Shimizu, D; Umeda, S; Tanaka, H; Hattori, N; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Fujiwara, M; Kodera, Y

CANCER GENOMICS & PROTEOMICS Vol. 22 ( 1 ) page： 55 - 69 2025.1

Factors Affecting the Prognosis after Primary Tumor Resection for Patients with Metastatic Colorectal Cancer with Synchronous Peritoneal Metastasis: A Multi-center, Prospective, Observational Study.

Kagami S, Funahashi K, Kobayashi H, Kotake K, Kawasaki M, Kinugasa Y, Ueno H, Maeda K, Suto T, Itabashi M, Ozawa H, Koyama F, Noura S, Ishida H, Ohue M, Kiyomatsu T, Ishihara S, Koda K, Baba H, Kawada K, Hashiguchi Y, Goi T, Toiyama Y, Tomita N, Sunami E, Fujita F, Watanabe J, Hakamada K, Nakayama G, Sugihara K, Ajioka Y

Journal of the anus, rectum and colon Vol. 9 ( 1 ) page： 134 - 144 2025

Genome-wide microRNA Analysis Identified miR-210-3p Over-expression in Pancreatic Cancer Tissues as a Predictor of their Local Invasiveness

Otsu, T; Hayashi, M; Fujita, K; Kobayashi, D; Nakagawa, N; Kurimoto, K; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH Vol. 44 ( 11 ) page： 4709 - 4721 2024.11

Fukuda, Y; Morioka, H; Yamamoto, S; Iguchi, M; Umeda, S; Asahara, T; Kanda, K; Oka, K; Nakayama, G; Yagi, T

JOURNAL OF INFECTION AND CHEMOTHERAPY Vol. 30 ( 7 ) page： 664 - 667 2024.7

Prognostic Impact of CDKN2A Mutations Associated With Smoking and Drinking History in Japanese Digestive Cancers

Fujita, K; Hayashi, M; Nakagawa, N; Kurimoto, K; Inokawa, Y; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH Vol. 44 ( 6 ) page： 2699 - 2707 2024.6

Chronologic improvement in survival of first-line oxaliplatin based chemotherapy plus targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database

Takeda, Y; Yamazaki, K; Saltz, L; Douillard, JY; Punt, CJA; Van Cutsem, E; Bokemeyer, C; Venook, A; Koopman, M; Heinemann, V; Cremolini, C; Hecht, JR; Schmoll, HJEV; Nakayama, G; Sugihara, K; Oki, E; André, T; Shi, Q; De Gramont, A; Yoshino, T

ANNALS OF ONCOLOGY Vol. 35 page： S38 - S38 2024.6

Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 31 ( 5 ) page： 3417 - 3425 2024.5

Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways

Ito, Y; Kanda, M; Sasahara, M; Tanaka, C; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

GASTRIC CANCER Vol. 27 ( 3 ) page： 506 - 518 2024.5

ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 31 ( 5 ) page： 3477 - 3478 2024.5

Outcomes of surgical treatment for enterovesical fistula in Crohn's disease.

Hattori N, Nakayama G, Umeda S, Nakamura M, Yamamura T, Sawada T, Nakanishi K, Shimizu D, Kanda M, Hayashi M, Tanaka C, Kodera Y

Nagoya journal of medical science Vol. 86 ( 2 ) page： 280 - 291 2024.5

Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis

Sasahara, M; Kanda, M; Tanaka, C; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

INTERNATIONAL JOURNAL OF CANCER Vol. 154 ( 7 ) page： 1272 - 1284 2024.4

Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy: A Retrospective Analysis

Agatsuma, Y; Nakanishi, K; Tanaka, C; Kanda, M; Shimizu, D; Umeda, S; Kurimoto, K; Inokawa, Y; Takami, H; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

ANTICANCER RESEARCH Vol. 44 ( 4 ) page： 1645 - 1651 2024.4

Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients

Shinozuka, T; Kanda, M; Sato, Y; Shimizu, D; Tanaka, C; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

CANCER MEDICINE Vol. 12 ( 24 ) page： 22185 - 22195 2023.12

Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria

Tanaka, N; Takami, H; Hayashi, M; Inokawa, Y; Kurimoto, K; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES Vol. 30 ( 11 ) page： 1273 - 1281 2023.11

Risk Stratification by Tissue GAD1 Expression Level in Curatively Resected Esophageal Squamous Cell Carcinoma

Kishida, T; Kanda, M; Sato, Y; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

CANCER GENOMICS & PROTEOMICS Vol. 20 ( 6 ) page： 617 - 625 2023.11

Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers

Shinozuka, T; Kanda, M; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

SCIENTIFIC REPORTS Vol. 13 ( 1 ) page： 15540 2023.9

A proposed new Japanese classification of synchronous peritoneal metastases from colorectal cancer: A multi-institutional, prospective, observational study conducted by the Japanese Society for Cancer of the Colon and Rectum

Kobayashi, H; Kotake, K; Kawasaki, M; Kanemitsu, Y; Kinugasa, Y; Ueno, H; Maeda, K; Suto, T; Itabashi, M; Funahashi, K; Ozawa, H; Koyama, F; Noura, S; Ishida, H; Ohue, M; Kiyomatsu, T; Ishihara, S; Koda, K; Baba, H; Kawada, K; Hashiguchi, Y; Goi, T; Toiyama, Y; Tomita, N; Sunami, E; Akagi, Y; Watanabe, J; Hakamada, K; Nakayama, G; Sugihara, K; Ajioka, Y

ANNALS OF GASTROENTEROLOGICAL SURGERY Vol. 7 ( 5 ) page： 765 - 771 2023.9

The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy

Obata, Y; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

SURGERY TODAY Vol. 53 ( 8 ) page： 964 - 972 2023.8

High Preoperative Platelet to Lymphocyte Ratio is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment

Sasahara, M; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Fujiwara, M; Nakayama, G; Kodera, Y

DIGESTIVE SURGERY Vol. 40 ( 1-2 ) page： 48 - 57 2023.7

High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients

Otsu, T; Hayashi, M; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH Vol. 43 ( 7 ) page： 3173 - 3181 2023.7

Optimal molecular-targeted therapies as first-line treatment for RAS wild-type, right-sided metastatic colorectal cancer from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Yamazaki, K; Takeda, Y; Misumi, T; Suzuki, M; Wakabayashi, M; Bando, H; Oki, E; Douillard, JY; Punt, CJA; Van Cutsem, E; Bokemeyer, C; Venook, AP; Maehara, Y; Heinemann, V; Cremolini, C; Nakayama, G; Andre, T; Shi, Q; De Gramont, A; Yoshino, T

JOURNAL OF CLINICAL ONCOLOGY Vol. 41 ( 16 ) 2023.6

Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection

Hayashi, M; Kobayashi, D; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL Vol. 75 ( 5 ) page： 1330 - 1339 2023.5

Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification

Nakamura, M; Okamura, Y; Ohshima, K; Sugiura, T; Ashida, R; Ohgi, K; Bando, E; Fujiya, K; Shiomi, A; Kagawa, H; Imamura, T; Nakayama, G; Kodera, Y; Uesaka, K; Ohike, N; Norose, T; Sasaki, K; Sugino, T; Ohnami, S; Nagashima, T; Urakami, K; Akiyama, Y; Yamaguchi, K

CANCER MEDICINE Vol. 12 ( 10 ) page： 11491 - 11502 2023.5

Impact of obstructive ventilatory impairment on intraoperative bleeding during laparoscopic hepatectomy

Nakamura, M; Okamura, Y; Sugiura, T; Ashida, R; Ohgi, K; Yamada, M; Otsuka, S; Nakayama, G; Kodera, Y; Uesaka, K

LANGENBECKS ARCHIVES OF SURGERY Vol. 408 ( 1 ) page： 122 2023.3

Perioperative changes in geriatric functions of elderly patients undergoing surgical resection for gastric cancer.

Tanaka, C; Kanda, M; Nakanishi, K; Umeda, S; Shimizu, D; Inokawa, Y; Takami, H; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y; Hattori, N

JOURNAL OF CLINICAL ONCOLOGY Vol. 41 page： 811 - 811 2023.2

Proposal of a coagulation score to predict postoperative survival of patients undergoing neoadjuvant therapy followed by subtotal esophagectomy for squamous cell carcinoma of the esophagus.

Sugiyama, F; Shimizu, D; Kanda, M; Tanaka, C; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 41 page： 448 - 448 2023.2

Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment

Nonogaki, I; Kanda, M; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Koike, M; Nakayama, G; Kodera, Y

WORLD JOURNAL OF SURGERY Vol. 47 ( 1 ) page： 217 - 226 2023.1

The effects of ustekinumab on small intestinal lesions and stenotic lesions

Wada, H; Murate, K; Nakamura, M; Furukawa, K; Kakushima, N; Yamamura, T; Maeda, K; Sawada, T; Ishikawa, E; Ishikawa, T; Ohno, E; Honda, T; Kawashima, H; Nakayama, G; Hattori, N; Umeda, S; Ishigami, M

NAGOYA JOURNAL OF MEDICAL SCIENCE Vol. 84 ( 4 ) page： 825 - 838 2022.11

ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

Yamanaka, M; Hayashi, M; Sonohara, F; Yamada, S; Tanaka, H; Sakai, A; Mii, S; Kobayashi, D; Kurimoto, K; Tanaka, N; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 29 ( 11 ) page： 7192 - 7193 2022.10

Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

ANNALS OF SURGICAL ONCOLOGY Vol. 29 ( 11 ) page： 7180 - 7189 2022.10

Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy

Tanaka, H; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

JOURNAL OF GASTROENTEROLOGY Vol. 57 ( 9 ) page： 640 - 653 2022.9

Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer br

Otsu, T; Inokawa, Y; Takami, H; Hayashi, M; Kurimoto, K; Tanaka, N; Tanaka, H; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH Vol. 42 ( 8 ) page： 3889 - 3894 2022.8

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer

Sakata, K; Kanda, M; Shimizu, D; Nakamura, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

INTERNATIONAL JOURNAL OF ONCOLOGY Vol. 60 ( 6 ) 2022.6

Direct Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin.

Mitsuma A, Ito Y, Shimokata T, Tanaka C, Uehara K, Nakayama G, Terasaki H, Ando Y

Cancer diagnosis & prognosis Vol. 2 ( 3 ) page： 330 - 335 2022.5

Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells

Umeda, S; Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

GASTRIC CANCER Vol. 25 ( 3 ) page： 558 - 572 2022.5

Drain Amylase Concentrations at 3 h After Gastrectomy Enhance Early Prediction of Postoperative Peripancreatic Inflammatory Fluid Collection

Nakanishi, K; Kanda, M; Tanaka, C; Takeda, S; Tanaka, K; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

WORLD JOURNAL OF SURGERY Vol. 46 ( 3 ) page： 648 - 655 2022.3

The significance of the time to arterial perfusion in intraoperative ICG angiography during colorectal surgery

Aiba, T; Uehara, K; Ogura, A; Tanaka, A; Yonekawa, Y; Hattori, N; Nakayama, G; Kodera, Y; Ebata, T; Nagino, M

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES Vol. 35 ( 12 ) page： 7227 - 7235 2021.12

Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy

Sunagawa, Y; Hayashi, M; Yamada, S; Tanabe, H; Kurimoto, K; Tanaka, N; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

CLINICAL EPIGENETICS Vol. 13 ( 1 ) page： 172 2021.12

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS Vol. 24 page： 100853 2021.12

Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells

Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Umeda, S; Miwa, T; Tanaka, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Iguchi, Y; Katsuno, M; Kodera, Y

ONCOGENE Vol. 40 ( 36 ) page： 5495 - 5504 2021.9

A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes

Yamanaka, M; Hayashi, M; Yamada, S; Sonohara, F; Takami, H; Inokawa, Y; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 41 ( 8 ) page： 3933 - 3940 2021.8

G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer

Tanaka, H; Kanda, M; Miwa, T; Umeda, S; Sawaki, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

BRITISH JOURNAL OF CANCER Vol. 125 ( 2 ) page： 220 - 228 2021.7

High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences

Hayashi, M; Yamada, S; Tanabe, H; Takami, H; Inokawa, Y; Sonohara, F; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL Vol. 73 ( 6 ) page： 996 - 1003 2021.7

The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer

Suzuki, Y; Ogura, A; Uehara, K; Aiba, T; Ohara, N; Murata, Y; Jinno, T; Mishina, T; Sato, Y; Hattori, N; Nakayama, G; Kodera, Y; Ebata, T

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY Vol. 26 ( 7 ) page： 1264 - 1271 2021.7

Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma

Nakagawa, N; Sonohara, F; Tanaka, K; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ONCOLOGY LETTERS Vol. 22 ( 1 ) page： 538 2021.7

miR-23b-3p Plays an Oncogenic Role in Hepatocellular Carcinoma

Hayashi, M; Yamada, S; Kurimoto, K; Tanabe, H; Hirabayashi, S; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 28 ( 6 ) page： 3416 - 3426 2021.6

Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancer

Ogura, A; Uehara, K; Aiba, T; Sando, M; Tanaka, A; Ohara, N; Murata, Y; Sato, Y; Hattori, N; Nakayama, G; Ebata, T; Kodera, Y; Nagino, M

EJSO Vol. 47 ( 5 ) page： 1005 - 1011 2021.5

Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma

Hayashi, M; Yamada, S; Takano, N; Okamura, Y; Takami, H; Inokawa, Y; Sonohara, F; Tanaka, N; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

IN VIVO Vol. 35 ( 3 ) page： 1749 - 1760 2021.5

Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway

Miwa, T; Kanda, M; Shimizu, D; Umeda, S; Sawaki, K; Tanaka, H; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

BRITISH JOURNAL OF CANCER Vol. 124 ( 8 ) page： 1449 - 1460 2021.4

Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 28 ( 4 ) page： 2277 - 2286 2021.4

Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue

Sunagawa, Y; Yamada, S; Sonohara, F; Kurimoto, K; Tanaka, N; Suzuki, Y; Inokawa, Y; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

SCIENTIFIC REPORTS Vol. 11 ( 1 ) page： 6016 2021.3

Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer

Sasahara, M; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

ANTICANCER RESEARCH Vol. 41 ( 2 ) page： 609 - 617 2021.2

Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody

Hasegawa, H; Sugiyama, D; Kanda, M; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Nomoto, S; Fujiwara, M; Kodera, Y; Nishikawa, H

CANCER SCIENCE Vol. 112 page： 741 - 741 2021.2

Function and prognostic value of melanoma-associated antigen-D4 protein in esophageal squamous cell carcinoma

Sawaki, K; Kanda, M; Sato, Y; Shimizu, D; Uno, Y; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Fujiwara, M; Kodera, Y

CANCER SCIENCE Vol. 112 page： 531 - 531 2021.2

Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)

Nakayama, G; Takano, N; Taniguchi, H; Ishigure, K; Yokoyama, H; Teramoto, H; Hashimoto, R; Sakai, M; Ishiyama, A; Kinoshita, T; Hayashi, N; Nakamura, M; Hattori, N; Sato, Y; Umeda, S; Uehara, K; Aiba, T; Sonohara, F; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Murotani, K; Ando, M; Ando, Y; Muro, K; Kodera, Y

EUROPEAN JOURNAL OF CANCER Vol. 144 page： 61 - 71 2021.2

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Miwa, K; Oki, E; Enomoto, M; Ihara, K; Ando, K; Fujita, F; Tominaga, M; Mori, S; Nakayama, G; Shimokawa, M; Saeki, H; Baba, H; Mori, M; Akagi, Y

BMC CANCER Vol. 21 ( 1 ) page： 23 2021.1

Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy

Sunagawa, Y; Yamada, S; Kato, Y; Sonohara, F; Takami, H; Inokawa, Y; Hayashi, M; Nakayama, G; Koike, M; Kodera, Y

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES Vol. 28 ( 1 ) page： 86 - 94 2021.1

Pancreatic Fat and Body Composition Measurements by Computed Tomography are Associated with Pancreatic Fistula After Pancreatectomy

Tanaka, K; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 28 ( 1 ) page： 530 - 538 2021.1

Sonohara, F; Yamada, S; Kurimoto, K; Inokawa, Y; Takami, H; Hayashi, M; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

PANCREAS Vol. 50 ( 1 ) page： 37 - 46 2021.1

Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue

Nakagawa, N; Tanaka, K; Sonohara, F; Kandimalla, R; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 40 ( 12 ) page： 6665 - 6676 2020.12

AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer

Nakamura, S; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 40 ( 12 ) page： 6713 - 6721 2020.12

What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?

Ogura, A; Uehara, K; Aiba, T; Hattori, N; Nakayama, G; Maeda, O; Ando, Y; Kodera, Y; Ebata, T; Nagino, M

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE Vol. 35 ( 11 ) page： 2073 - 2080 2020.11

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5′-Deoxy-5-fluorocytidine, and Creatinine Clearance

Inaishi, T; Fujita, KI; Matsumoto, N; Shimokata, T; Maeda, O; Kikumori, T; Hattori, N; Nakayama, G; Ando, Y

IN VIVO Vol. 34 ( 6 ) page： 3539 - 3544 2020.11

AnOpen-Label Single-ArmPhaseIIStudy of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical StageIIISquamous Cell Carcinoma of the Esophagus

Kanda, M; Koike, M; Iwata, N; Shimizu, D; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Omae, K; Nakayama, G; Kodera, Y

ONCOLOGIST Vol. 25 ( 11 ) page： E1650 - E1654 2020.11

Characteristics Associated with Nodal and Distant Recurrence after Curative Resection of Squamous Cell Carcinoma of the Thoracic Esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Hayashi, M; Hattori, N; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Vol. 231 ( 4 ) page： E121 - E121 2020.10

An outcome analysis of predictive factors for portal or splenic vein thrombosis after distal pancreatectomy

Tanaka, N; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

SURGERY TODAY Vol. 50 ( 10 ) page： 1282 - 1289 2020.10

STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer

Nakamura, S; Kanda, M; Shimizu, D; Sawaki, K; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

CANCER GENOMICS & PROTEOMICS Vol. 17 ( 5 ) page： 509 - 516 2020.9

The impact of cancer stem cell markers in the tissues of pancreatic ductal adenocarcinoma for prognosis after surgical resections

Inokawa, Y; Yamada, S; Hayashi, M; Sunagawa, Y; Sonohara, F; Takami, H; Hattori, N; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

CANCER RESEARCH Vol. 80 ( 16 ) 2020.8

Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer

Mukai, T; Uehara, K; Aiba, T; Ogura, A; Tsuzuki, T; Tanaka, A; Sando, M; Ohara, N; Sato, Y; Hattori, N; Nakayama, G; Kodera, Y; Nagino, M

SURGERY TODAY Vol. 50 ( 8 ) page： 912 - 919 2020.8

Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan

Taniguchi, H; Uehara, K; Nakayama, G; Nakayama, H; Aiba, T; Hattori, N; Kataoka, M; Nakano, Y; Kawase, Y; Okochi, O; Matsuoka, H; Utsunomiya, S; Sakamoto, E; Mori, Y; Umeda, S; Shikano, T; Komori, K; Tajika, M; Kadowaki, S; Muro, K; Yatabe, Y

TRANSLATIONAL ONCOLOGY Vol. 13 ( 7 ) page： 100786 2020.7

Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

Sunagawa, Y; Yamada, S; Sato, Y; Morimoto, D; Sonohara, F; Takami, H; Inokawa, Y; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 27 ( 6 ) page： 2081 - 2089 2020.6

Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer

Umeda, S; Kanda, M; Miwa, T; Tanaka, H; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

INTERNATIONAL JOURNAL OF CANCER Vol. 146 ( 10 ) page： 2865 - 2876 2020.5

Clinical impact of additional therapy for residual pancreatic cancer

Yamada, S; Sonohara, F; Tashiro, M; Murotani, K; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

SURGERY TODAY Vol. 50 ( 5 ) page： 440 - 448 2020.5

Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer

Morimoto, D; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

PANCREAS Vol. 49 ( 5 ) page： 699 - 705 2020.5

Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Hattori, N; Hayashi, M; Omae, K; Yamada, S; Nakayama, G; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 27 ( 4 ) page： 1233 - 1240 2020.4

Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer

Sonohara, F; Yamada, S; Takeda, S; Hayashi, M; Suenaga, M; Sunagawa, Y; Tashiro, M; Takami, H; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANTICANCER RESEARCH Vol. 40 ( 4 ) page： 1843 - 1853 2020.4

Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer

Nakagawa, N; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

ANNALS OF SURGICAL ONCOLOGY Vol. 27 ( 3 ) page： 887 - 895 2020.3

Randomized phase II trial of CAPOX with continuous versus intermittent use of oxaliplatin as an adjuvant chemotherapy after curative resection of stage II/III colon cancer (CCOG-1302 study)

Nakamura, M; Nakayama, G; Ishigure, K; Mashita, N; Yokoyama, H; Hattori, N; Uehara, K; Yamada, S; Koike, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 4 ) 2020.2

Predictive value of the modified systemic inflammation score in patients undergoing curative resection of squamous cell carcinoma of the esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Sonohara, F; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 4 ) 2020.2

A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage a the anastomotic site after esophagectomy

Kanda, M; Koike, M; Fukaya, M; Miyata, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Murotani, K; Fujiwara, M; Nagino, M; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE Vol. 82 ( 1 ) page： 33 - 37 2020.2

The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness

Hirabayashi, S; Hayashi, M; Nakayama, G; Mii, S; Hattori, N; Tanabe, H; Kanda, M; Tanaka, C; Kobayashi, D; Yamada, S; Koike, M; Fujiwara, M; Takahashi, M; Kodera, Y

ANTICANCER RESEARCH Vol. 40 ( 1 ) page： 201 - 211 2020.1

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

Hattori, N; Nakayama, G; Uehara, K; Aiba, T; Ishigure, K; Sakamoto, E; Tojima, Y; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Nagino, M; Kodera, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY Vol. 25 ( 1 ) page： 118 - 125 2020.1

Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

PANCREAS Vol. 48 ( 10 ) page： 1528 - 1528 2019.11

Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma

Sonohara, F; Yamada, S; Tanaka, N; Tashiro, M; Sunagawa, Y; Morimoto, D; Tanaka, H; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

HEPATOLOGY RESEARCH Vol. 49 ( 11 ) page： 1305 - 1315 2019.11

Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines

Miwa, T; Kanda, M; Umeda, S; Tanaka, H; Shimizu, D; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

IN VIVO Vol. 33 ( 6 ) page： 1785 - 1792 2019.11

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma

Uno, Y; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 39 ( 11 ) page： 6015 - 6023 2019.11

Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer

Sawaki, K; Kanda, M; Umeda, S; Miwa, T; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 39 ( 11 ) page： 6125 - 6133 2019.11

Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis

Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Kodera, Y

BMC SURGERY Vol. 19 ( 1 ) page： 143 2019.10

Randomized phase II trial of CAPOX with planned oxaliplatin stop-and-go strategy as adjuvant chemotherapy after curative resection of colon cancer (CCOG-1302 study)

Yokoyama, H; Nakayama, G; Ishigure, K; Hayashi, N; Tanaka, K; Tsutsuyama, M; Hattori, N; Yamada, S; Kodera, Y

ANNALS OF ONCOLOGY Vol. 30 2019.10

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens

Sonohara, F; Yamada, S; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

EJSO Vol. 45 ( 10 ) page： 1895 - 1900 2019.10

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.

Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y

HPB : the official journal of the International Hepato Pancreato Biliary Association Vol. 21 ( 9 ) page： 1211 - 1218 2019.9

Functions of FRAS1 as a driver gene of liver metastasis from gastric cancer analyzed by the genome editing technology

Umeda, S; Kanda, M; Tanaka, H; Sonohara, F; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER RESEARCH Vol. 79 ( 13 ) 2019.7

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy

Miwa, T; Kanda, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

JOURNAL OF GASTRIC CANCER Vol. 19 ( 2 ) page： 183 - 192 2019.6

Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y

Annals of surgical oncology Vol. 26 ( 5 ) page： 1535 - 1543 2019.5

Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial.

Tomida A, Uehara K, Hiramatsu K, Maeda A, Sakamoto E, Okada Y, Kurumiya Y, Nakayama G, Nakamura M, Aiba T, Nagino M, Of the Nagoya Surgical Oncology Group.

International journal of clinical oncology Vol. 24 ( 4 ) page： 403 - 410 2019.4

Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer

Uno Yasuo, Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

ANNALS OF SURGICAL ONCOLOGY Vol. 26 ( 3 ) page： 836 - 844 2019.3

Prediction of peritoneal recurrences of gastric cancer by qPCR analysis of peritoneal lavage fluids.

Nakanishi, K; Kanda, M; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 37 ( 4 ) 2019.2

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy

Niwa Yukiko, Yamada Suguru, Sonohara Fuminori, Kurimoto Keisuke, Hayashi Masamichi, Tashiro Mitsuru, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF TRANSLATIONAL MEDICINE Vol. 17 ( 1 ) page： 1 2019.1

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma

Sonohara Fuminori, Yamada Suguru, Tanaka Nobutake, Suenaga Masaya, Takami Hideki, Hayashi Masamichi, Niwa Yukiko, Sugimoto Hiroyuki, Hattori Norifumi, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

ANNALS OF GASTROENTEROLOGICAL SURGERY Vol. 3 ( 1 ) page： 65 - 74 2019.1

A New Biomarker for Peritoneal Lavage Using Digital PCR in Patients with Pancreatic Ductal Adenocarcinoma

Suenaga Masaya, Yamada Suguru, Hayashi Masamichi, Kanda Mitsuro, Tanaka Chie, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 650 - 650 2018.12

Pattern-specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer

Tanaka Haruyoshi, Kanda Mitsuro, Suenaga Masaya, Hayashi Masamichi, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 1128 - 1128 2018.12

Integrated multigene expression panel to prognosticate patients with gastric cancer

Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Chie, Hayashi Masamichi, Suenaga Masaya, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 769 - 769 2018.12

FRAS1 expression reflects the malignancy potential of gastric cancer

Umeda Shinichi, Kanda Mitsuro, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 1128 - 1128 2018.12

Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma

Umeda Shinichi, Kanda Mitsuro, Koike Masahiko, Tanaka Haruyoshi, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Kodera Yasuhiro

ONCOLOGY REPORTS Vol. 40 ( 6 ) page： 3772 - 3780 2018.12

Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer

Sawaki Koichi, Kanda Mitsuro, Suenaga Masaya, Hayashi Masamichi, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 765 - 765 2018.12

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification

Morimoto Daishi, Yamada Suguru, Murotani Kenta, Sonohara Fuminori, Takami Hideki, Suenaga Masaya, Hayashi Masamichi, Niwa Yukiko, Tashiro Mitsuru, Hattori Norifumi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

PANCREAS Vol. 47 ( 10 ) page： 1350 - 1356 2018.11

Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis

Kobayashi Daisuke, Kanda Mitsuro, Tanaka Chie, Sonohara Fuminori, Suenaga Masaya, Takami Hideki, Hattori Norifumi, Niwa Yukiko, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 page： 98 - 98 2018.11

Transanal extended rectal surgery with lateral pelvic lymph node dissection

Aiba T., Uehara K., Mukai T., Hattori N., Nakayama G., Nagino M.

TECHNIQUES IN COLOPROCTOLOGY Vol. 22 ( 11 ) page： 893 - 894 2018.11

Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer

Tashiro Mitsuru, Yamada Suguru, Sonohara Fuminori, Takami Hideki, Suenaga Masaya, Hayashi Masamichi, Niwa Yukiko, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

ANNALS OF SURGICAL ONCOLOGY Vol. 25 ( 11 ) page： 3365 - 3371 2018.10

Expression of sushi domain containing two reflects the malignant potential of gastric cancer

Umeda Shinichi, Kanda Mitsuro, Miwa Takashi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

CANCER MEDICINE Vol. 7 ( 10 ) page： 5194 - 5204 2018.10

A longitudinal study of a new point-of-care nerve conduction device for quantitative assessment of chemotherapy-induced peripheral neurotoxicity

Matsuoka, A; Maeda, O; Mitsuma, A; Uehara, K; Nakayama, G; Nagino, M; Kodera, Y; Ando, Y

ANNALS OF ONCOLOGY Vol. 29 2018.10

Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms.

Yamada S, Fujii T, Hirakawa A, Takami H, Suenaga M, Hayashi M, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y

Pancreas Vol. 47 ( 8 ) page： 974 - 979 2018.9

Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer

Tanaka Haruyoshi, Kanda Mitsuro, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Umeda Shinichi, Shibata Masahiro, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Iwata Naoki, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

MOLECULAR CANCER RESEARCH Vol. 16 ( 9 ) page： 1420 - 1429 2018.9

Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma

Kato Yoshiyasu, Yamada Suguru, Suenaga Masaya, Takami Hideki, Niwa Yukiko, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

PANCREAS Vol. 47 ( 7 ) page： 823 - 829 2018.8

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)

Nakayama Goro, Mitsuma Ayako, Sunagawa Yuki, Ishigure Kiyoshi, Yokoyama Hiroyuki, Matsui Takanori, Nakayama Hiroshi, Nakata Kazuhiko, Ishiyama Akiharu, Asada Takahiro, Umeda Shinichi, Ezaka Kazuhiro, Hattori Norifumi, Takami Hideki, Kobayashi Daisuke, Tanaka Chie, Kanda Mitsuro, Yamada Suguru, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Murotani Kenta, Ando Yuichi, Kodera Yasuhiro

ONCOLOGIST Vol. 23 ( 8 ) page： 919 - 927 2018.8

Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer

Sawaki Koichi, Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

ANNALS OF SURGICAL ONCOLOGY Vol. 25 ( 7 ) page： 2083 - 2090 2018.7

Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer

Tanaka Nobutake, Yamada Suguru, Sonohara Fuminori, Suenaga Masaya, Hayashi Masamichi, Takami Hideki, Niwa Yukiko, Hattori Norifumi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

SCIENTIFIC REPORTS Vol. 8 ( 1 ) page： 9846 2018.6

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study

Oki Eiji, Kato Takeshi, Bando Hideaki, Yoshino Takayuki, Muro Kei, Taniguchi Hiroya, Kagawa Yoshinori, Yamazaki Kentaro, Yamaguchi Tatsuro, Tsuji Akihito, Iwamoto Shigeyoshi, Nakayama Goro, Emi Yasunori, Touyama Tetsuo, Nakamura Masato, Kotaka Masahito, Sakisaka Hideki, Yamanaka Takeharu, Kanazawa Akiyoshi

CLINICAL COLORECTAL CANCER Vol. 17 ( 2 ) page： 147 - 155 2018.6

IDENTIFICATION OF MOLECULES DRIVING HEPATIC METASTASIS FORMATION OF GASTRIC CANCER CELLS

Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Takami Hideki, Hattori Norifumi, Niwa Yukiko, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

GUT Vol. 67 page： A5 - A5 2018.6

A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer

Kanda Mitsuro, Murotani Kenta, Tanaka Haruyoshi, Miwa Takashi, Umeda Shinichi, Tanaka Chie, Kobayashi Daisuke, Hayashi Masamichi, Hattori Norifumi, Suenaga Masaya, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

CANCER MEDICINE Vol. 7 ( 6 ) page： 2463 - 2471 2018.6

Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study)

Asada Takahiro, Nakayama Goro, Tanaka Chie, Kobayashi Daisuke, Ezaka Kazuhiro, Hattori Norifumi, Kanda Mitsuro, Yamada Suguru, Koike Masahiko, Kodera Yasuhiro

SURGERY TODAY Vol. 48 ( 6 ) page： 609 - 617 2018.6

Significance of Lysyl oxidase-like 2 gene expression on the epithelial-mesenchymal status of hepatocellular carcinoma

Ninomiya Go, Yamada Suguru, Hayashi Masamichi, Takeda Shigeomi, Suenaga Masaya, Takami Hideki, Kanda Mitsuro, Iwata Naoki, Niwa Yukiko, Tanaka Chie, Kobayashi Daisuke, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

ONCOLOGY REPORTS Vol. 39 ( 6 ) page： 2664 - 2672 2018.6

Integrated multigene expression panel to prognosticate patients with gastric cancer.

Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y

Oncotarget Vol. 9 ( 27 ) page： 18775-18785 2018.4

Clinical implication of nutrition for neoadjuvant therapy and impact of nutritional support in pancreatic cancer.

Tashiro Mitsuru, Yamada Suguru, Fujii Tsutomu, Hattori Norifumi, Takami Hideki, Suenaga Masaya, Niwa Yukiko, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) page： . 2018.2

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.

Yamada Suguru, Fujii Tsutomu, Takano Nao, Takami Hideki, Suenaga Masaya, Niwa Yukiko, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Kobayashi Daisuke, Tanaka Chie, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) page： . 2018.2

Identification of a novel molecule target for the diagnosis, prediction, and treatment of hepatic metastasis of gastric cancer.

Kanda Mitsuro, Tanaka Haruyoshi, Miwa Takashi, Kobayashi Daisuke, Tanaka Chie, Takami Hideki, Hayashi Masamichi, Iwata Naoki, Niwa Yukiko, Yamada Suguru, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) page： . 2018.2

Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).

Ezaka Kazuhiro, Nakayama Goro, Yokoyama Hiroyuki, Matsui Takanori, Umeda Shinichi, Sunagawa Yuki, Murotani Kenta, Ando Yuichi, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) page： . 2018.2

Randomized phase II trial of CapOX plus bevacizumab versus CapIRI plus bevacizumab as first-line treatment in Japanese patients with metastatic colorectal cancer (CCOG-1201).

Sasahara Masahiro, Nakayama Goro, Ishigure Kiyoshi, Yokoyama Hiroyuki, Uehara Keisuke, Ishiyama Akiharu, Matsui Takanori, Nakayama Hiroshi, Kobayashi Daisuke, Umeda Shinichi, Sunagawa Yuki, Murotani Kenta, Ando Yuichi, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) page： . 2018.2

Effectiveness of plasma activated lactated Ringer's solution on pancreatic cancer cells in vitro and in vivo

Sato Yusuke, Yamada Suguru, Takeda Shigeomi, Kanda Mitsuo, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

CANCER SCIENCE Vol. 109 page： 707 - 707 2018.1

Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer

Sunagawa Y., Nakayama G., Hattori N., Ezaka K., Uda H., Umeda S., Sato B., Yamada S., Sugimito H., Koike M., Kodera Y.

ANNALS OF ONCOLOGY Vol. 28 page： . 2017.11

FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer

Tanaka Haruyoshi, Kanda Mitsuro, Shimizu Dai, Tanaka Chie, Kobayashi Daisuke, Hayashi Masamichi, Iwata Naoki, Yamada Suguru, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Fujiwara Michitaka, Niwa Yukiko, Kodera Yasuhiro

ANNALS OF SURGICAL ONCOLOGY Vol. 24 ( 11 ) page： 3438 - 3445 2017.10

Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society

Yamada Suguru, Fujii Tsutomu, Takami Hideki, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Sugimoto Hiroyuki, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

SURGERY Vol. 162 ( 4 ) page： 784 - 791 2017.10

Involvement of the immunoregulator MZB1 in progression of gastric cancer

Tanaka Y., Kanda M., Tanaka C., Kobayashi D., Tanaka H., Takami H., Hayashi M., Iwata N., Niwa Y., Yamada S., Nakayama G., Sugimoto H., Koike M., Fujiwara M., Kodera Y.

ANNALS OF ONCOLOGY Vol. 28 page： . 2017.9

Primary efficacy results and clinical impact of UGT1A1 genotype on safety from a Phase II study of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: The QUATTRO study

Bando H., Kato T., Yoshino T., Muro K., Yamazaki K., Yamaguchi T., Oki E., Iwamoto S., Tsuji A., Nakayama G., Emi Y., Touyama T., Nakamura M., Kotaka M., Kagawa Y., Taniguchi H., Sakisaka H., Yamanaka T., Kanazawa A.

ANNALS OF ONCOLOGY Vol. 28 page： . 2017.9

Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer

Tanaka Yuri, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Mizuno Akira, Iwata Naoki, Hayashi Masamichi, Niwa Yukiko, Takami Hideki, Yamada Suguru, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Fujiwara Michitaka, Kodera Yasuhiro

GASTRIC CANCER Vol. 20 ( 4 ) page： 736 - 743 2017.7

Stapling an extracorporeal Billroth-I anastomosis by the complete double stapling technique after laparoscopy-assisted distal gastrectomy

Tanaka Chie, Fujiwara Michitaka, Kanda Mitsuro, Murotani Kenta, Iwata Naoki, Hayashi Masamichi, Kobayashi Daisuke, Yamada Suguru, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujii Tsutomu, Kodera Yasuhiro

ASIAN JOURNAL OF ENDOSCOPIC SURGERY Vol. 10 ( 2 ) page： 137 - 142 2017.5

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Nakayama Goro, Ishigure Kiyoshi, Yokoyama Hiroyuki, Uehara Keisuke, Kojima Hiroshi, Ishiyama Akiharu, Hayashi Naomi, Takano Nao, Hattori Norifumi, Kobayashi Daisuke, Tanaka Chie, Hayashi Masamichi, Kanda Mitsuro, Yamada Suguru, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Murotani Kenta, Ando Yuichi, Kodera Yasuhiro

BMC CANCER Vol. 17 ( 1 ) page： 243 2017.4

Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study

Ninomiya Go, Fujii Tsutomu, Yamada Suguru, Yabusaki Norimitsu, Suzuki Kojiro, Iwata Naoki, Kanda Mitsuro, Hayashi Masamichi, Tanaka Chie, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

INTERNATIONAL JOURNAL OF SURGERY Vol. 39 page： 45 - 51 2017.3

The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer

Asano Tomonari, Yamada Suguru, Fujii Tsutomu, Yabusaki Norimitsu, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

INTERNATIONAL JOURNAL OF SURGERY Vol. 39 page： 169 - 175 2017.3

GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer

Shimizu Dai, Kanda Mitsuro, Tanaka Haruyoshi, Kobayashi Daisuke, Tanaka Chie, Hayashi Masamichi, Iwata Naoki, Niwa Yukiko, Takami Hideki, Yamada Suguru, Fujii Tsutomu, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

SCIENTIFIC REPORTS Vol. 7 page： 42089 2017.2

The Charlson age comorbidity index to predict prognosis in patients with resected pancreatic cancer.

Asano Tomonari, Fujii Tsutomu, Yamada Suguru, Yabusaki Norimitsu, Ninomiya Go, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

JOURNAL OF CLINICAL ONCOLOGY Vol. 35 ( 4 ) page： . 2017.2

Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer.

Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y